{"id":"W2913393208","doi":"10.1016/j.jaip.2019.01.054","title":"Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks","year":2019,"lang":"en","type":"article","venue":"The Journal of Allergy and Clinical Immunology In Practice","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre de Santé et de Services Sociaux de la Vieille-Capitale; Ottawa Allergy Research Corporation; McMaster University Medical Centre","funders":"Janssen Pharmaceuticals; Genentech; Grifols; Swedish Orphan Biovitrum; BioCryst; AbbVie; Celgene; Novartis; Meso Scale Diagnostics; U.S. Department of Defense; Sanofi; Arrowhead Pharmaceuticals; Merck; GlaxoSmithKline; Viropharma; School of Public Health, University of California Berkeley; Pfizer; CSL Behring; Shire; AstraZeneca; Alnylam Pharmaceuticals; Boehringer Ingelheim; Astellas Pharma US","keywords":"Hereditary angioedema; Medicine; Angioedema; C1-inhibitor; Term (time); MEDLINE; Intensive care medicine; Dermatology; Pediatrics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001648569,0.0001447028,0.0005722066,0.00007365539,0.00005166893,0.000007858581,0.0001349706,0.000183519,0.00008320298],"category_scores_gemma":[0.0004765894,0.00008430917,0.0001981869,0.00008244126,0.0001981651,0.0002430719,0.00003512564,0.0003845925,0.00000324779],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002503339,"about_ca_system_score_gemma":0.0001394613,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002205792,"about_ca_topic_score_gemma":0.00004167076,"domain_scores_codex":[0.9980749,0.0003602338,0.001031047,0.000150515,0.000203085,0.0001802114],"domain_scores_gemma":[0.9951378,0.003116486,0.001117016,0.000278858,0.0002988137,0.00005106969],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.177508,0.004269175,0.7536749,0.00006711162,0.01842462,0.000259606,0.001482216,0.00005805616,0.001526576,0.0005125164,0.0007262355,0.04149099],"study_design_scores_gemma":[0.0161511,0.02668479,0.9475653,0.0004254837,0.001118041,0.003412608,0.001523479,0.00004175521,0.0005894431,0.0002433552,0.002081053,0.0001636334],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9857485,0.007789679,0.0001353389,0.0051112,0.0005897283,0.0004630508,0.000001326659,0.000006456445,0.0001546942],"genre_scores_gemma":[0.9842411,0.01331149,0.0006219179,0.0005773852,0.000176222,0.000003876163,0.000005664038,0.00001785568,0.001044533],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1938904,"threshold_uncertainty_score":0.3438028,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03321364454945547,"score_gpt":0.3698811433435542,"score_spread":0.3366674987940987,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}